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Background: Multi-disciplinary heart failure (HF) clinics have been shown to improve outcomes for HF patients in
randomized clinical trials. However, it is unclear how widely available specialized HF clinics are in Ontario. Also, the
service models of current clinics have not been described. It is therefore uncertain whether the efficacy of HF clinics
in trials is generalizable to the HF clinics currently operating in the province.
Methods: As part of a comprehensive evaluation of HF clinics in Ontario, we performed an environmental scan to
identify all HF clinics operating in 2010. A semi-structured interview was conducted to understand the scope of
practice. The intensity and complexity of care offered were quantified through the use of a validated instrument,
and clinics were categorized as high, medium or low intensity clinics.
Results: We identified 34 clinics with 143 HF physicians. We found substantial regional disparity in access to care
across the province. The majority of HF physicians were cardiologists (81%), with 81% of the clinics physically based
in hospitals, of which 26% were academic centers. There was a substantial range in the complexity of services
offered, most notably in the intensity of education and medication management services offered. All the clinics
focused on ambulatory care, with only one having an in-patient focus. None of the HF clinics had a home-based
component to care.
Conclusions: Multiple HF clinics are currently operating in Ontario with a wide spectrum of care models. Further
work is necessary to understand which components lead to improved patient outcomes.Background
Heart failure (HF) is a complex, progressive syndrome
characterized by abnormal heart function resulting in
poor exercise tolerance, recurrent hospitalizations, and
reductions in both quality of life, and survival [1]. Al-
though tremendous progress has been made in pharma-
cologic and device therapy, HF patients continue to have
a poor prognosis, with an annual mortality ranging from
5% to 50% [1]. The incidence of HF is projected to in-
crease, with estimates suggesting a three-fold increase in
HF hospitalizations over the next decade [2]. Alternative
targeted health care delivery models have therefore been* Correspondence: wijeysundera@gmail.com
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both quality of life and survival [3].
Disease management through multi-disciplinary com-
munity care clinics has been shown to improve patient
outcomes in different health conditions, including dia-
betes, chronic kidney disease, and cancer [4,5]. The poten-
tial benefits of a multi-disciplinary strategy in HF include
improved utilization and adherence with evidence-based
medications. This model of care may also address the
complex interplay between medical, psychosocial, and be-
havioural factors facing these patients and their caregivers
[3]. Multiple previous randomized studies and meta-
analyses have evaluated the efficacy of such clinics with
some suggesting a reduction in mortality in excess of 20%
[1,3,6]. However, interpreting this literature is challenging
because of substantial heterogeneity in the composition of
the HF clinics, the interventions they offer, and the popu-
lation studied [3,7].entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 1 Seed heart failure clinics
Clinic name and location
1. Cornwall: Cornwall Community Hospital
2. Hamilton: Heart Function Clinic - Hamilton Health Sciences
Corporation
3. Kingston: Hotel Dieu Hospital
4. Kitchener: St. Mary's Hospital
5. London: London Health Sciences Centre
6. Oakville: Oakville-Trafalgar Memorial Hospital
7. Orillia: Orillia Soldiers' Memorial Hospital
8. Ottawa: University of Ottawa Heart Institute
9. Owen Sound: Grey Bruce Health Services
10. Picton: Prince Edward Family Health Team Heart Failure Clinic
11. Toronto: University Health Network (UHN) (1)
12. Toronto: University Health Network (UHN) (2)
13. Toronto: Mt Sinai Heart Function Clinic
14. Toronto: St Michael’s Hospital Heart Function Clinic
15. Toronto: Sunnybrook Hospital Heart Function Clinic
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cific funding from the Ontario Ministry of Health and
Long Term Care (MOHLTC), the third party payer for
government insured health services in the province. It is
not known how widely available specialized HF clinics are
in Ontario, nor has their composition, or the services they
offer, been described. Therefore, it is unclear if the efficacy
of HF clinics in randomized trials is generalizable to the
HF clinics currently in place in Ontario. Our objective was
to address these important gaps in knowledge, through a
comprehensive field evaluation, whereby real world prac-
tice for HF patients in Ontario was assessed in 2010. Spe-
cially, we aimed to understand the current availability of
specialized HF clinics in the province, and the intensity
and complexity of services offered.
Methods
Canada is divided into 13 distinct territories or pro-
vinces, with Ontario being the most populous. Based on
the most recent census, 12.2 million of Canada’s 31.6
million people lived in Ontario. The Ontario population
is concentrated around major urban areas, with only
15% living in rural settings, defined as a population less
than 1000 persons and less than 400 persons per km2.
There is universal access to medical care in Canada
without user-fees or out-of-pocket payments. Health
care funding is determined at the provincial level. In
2006, the Ontario Ministry of Health and Long-Term
Care transferred the responsibility for planning, integrat-
ing and funding of health services within the province to
14 regional Local Health Integration Networks (LHIN).
Identification of Heart Failure Clinics
For the purpose of this project, a specialized HF clinic
was defined as a clinic that consists at a minimum of a
physician and a nurse, one of whom has specialized
training/interest in HF. This definition is consistent with
that used in recent systematic reviews of HF clinics [8].
We utilized three approaches to identify clinics. First,
all hospitals listed on the MOHLTC site (www.health.
gov.on.ca) were contacted. Notices were posted in the
Cardiac Care Network (CCN) webpage. Finally, we used
snow-ball sampling, an approach often used in qualita-
tive or mixed methods research studies, to evaluate ‘hid-
den populations’ [9].
A hidden population is one in which a sample frame
(i.e. a list of all the members of the population) cannot
be constructed, thereby preventing probability sampling
[9]. An alternative that does not require a sampling
frame is snow-ball sampling, whereby new members are
selected from the social network of existing members of
the sample [9].
In this method, a number of seeds are first selected
[9]. These seeds are members of the hidden populationthat have been identified. The seeds are interviewed and
form stage 0 of the sampling process. The seeds identify
other members of the population, who are in turn
approached in the next generation of sampling (stage 1).
This process is continued until the desired sample size is
reached. This method has been successfully utilized in a
myriad of cardiac studies [10-12].
In our study, the initial seeds were the Ontario mem-
bers of the Canadian Heart Failure Network (CHFN)
and other sites identified by the expert panel (Table 1).
Established in 1999, the CHFN is a network of academic
and community based clinics that provide specialized
care to HF patients (www.cfna.ca). Importantly, the net-
work did not include all HF clinics in the province,
thereby necessitating further sampling.
The physician or nursing lead at each clinic was
approached and a semi-structured interview conducted
to establish the scope of the practice. The lead was asked
to identify any other HF clinics, which may serve
patients in the vicinity (1st sampling stage). We contin-
ued to accrue new sampling stages until no new clinics
were identified, at which point the sample was saturated.
Regional differences in access to HF Clinics
The boundaries of each LHIN were used to assess any
geographic inequalities in access to HF clinics. We first
determined the population size overall and of persons
greater than the age of 65 years in each LHIN. The num-
ber of prevalent HF cases in each LHIN is not known. To
approximate the burden of HF per LHIN, we used previ-
ously published data on the number of hospital discharges
per LHIN with a most responsible diagnosis of HF in the
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nual rate of HF hospital discharges per HF clinic in each
LHIN as another estimate of the regional distribution of
access to care.Semi-structured Interview
The semi-structured interview ascertained information
broadly on the characteristics of the clinics themselves
and the program service model. We used the HF Disease
Management Scoring Instrument (HF-DMSI), a vali-
dated questionnaire developed by Riegel and colleagues
to measure the intensity and complexity of each clinic’s
program service model across 10 categories [14]. Details
on the categories and the respective scoring algorithm
are found in Table 2 [14]. Two researchers (GT, WW)
independently scored each clinic based on the interview
transcripts.
Briefly, the HF-DMSI focused on the composition of
the HF team (single practitioner vs. multi-disciplinary
team) and the content of the HF intervention such as
education (scored from 0 to 4, with 4 as the more com-
prehensive education program), and medication manage-
ment (scored from 0 to 3). The environment of the HF
clinics was categorized as those that only focused on
inpatients with HF (score of 1) versus those that focused
only on outpatients seen in clinic (score of 2), those that
were home-based with the intervention taking place in
the patients’ residence (score of 3), with clinics that had
components in more than one setting receiving the
highest score of 4. Peer support, remote monitoring, and
the duration and complexity of contact were also mea-
sured. The instrument was designed to provide a separ-
ate score for each category. The HF-DMSI has content
validity and an excellent inter-rater reliability with a
intra-class correlation coefficient of 0.918 [14].
Because the HF-DMSI does not provide an overall
summary score, and could not be used to rank clinics,
we performed a concept mapping exercise, using an HF
expert panel. The concept mapping exercise consisted of
two parts [15,16]. In part 1, we determined the relative
importance of each of the 10 categories of the HF-DMSI,
based on consensus of the expert panel. In the second
part, each of the clinics identified were categorized by
the expert panel into three intensity groups, based on
their scores on the HF-DMSI, influenced by the implicit
weighting system revealed in part 1. Further description
of this process is found in Additional file 1 Appendix A.Institutional review board
The ethics review board of the University of Toronto
approved this protocol. When required by local institu-
tional regulations, separate institutional review board ap-
proval was acquired for each participating clinic. Consentfor the use of the structure survey results was obtained
from the physician lead for each identified HF clinic.
Results
HF clinic identification
Between May 2010, and August 2010, we identified a
total of 34 clinics through our sampling method, as seen
in Figure 1. From the initial 15 seed clinics identified
through the CHFN, three generations of snow-ball sam-
pling took place, at which point the sample was satu-
rated. Five clinics were identified through the CCN and
one HF clinic through contacting individual hospitals.
Of these clinics, 30 agreed to participate in the semi-
structured survey.
Regional distribution of HF clinics
The initial seed clinics were located in 9 of the Ontario
14 LHIN’s. We were able to identify HF clinics in all the
remaining LHINs except for the Central West and Erie
St Clair LHINs. There was substantial regional variation
in access to HF clinics. As apparent from Figure 2 and
Table 3, the identified HF clinics were concentrated in
the south and central regions of the province. Each HF
clinic served an average population of 353,800 with an
over 65-year-old population of 45,200. However, there
was a substantial range in the population served in the
LHINs with identified HF clinics, from 179,200 per clinic
in the Toronto Central LHIN, to 761,400 in the central
LHIN.
In order to estimate the burden of HF across Ontario,
we used data which showed over the 5 years from 1998
to 2002, 42,367 patients were discharged with a diagno-
sis of HF. As seen in Table 3, given the 34 clinics, on
average each HF clinic would be able to serve 200 HF
discharges per year. However, there was substantial re-
gional variability, with greater than a 7fold difference be-
tween LHINs with HF clinics. For example in Waterloo,
there was a HF clinic for 84 HF discharges, compared to
one HF clinic per 626 HF discharges in the North East
LHIN.
Clinic characteristics
Identified HF clinics had a mean of 138 new consults
(median 78; interquartile range 25–128) and 1020 visits
per year (median 675; interquartile range 200–1479).
However, there was substantial variation in their service
volume, as evidence in Figure 3, with two high volume
clinics which were outliers (clinic #17 and #25). Clinic #25
had 4900 annual visits, with 1400 new patients per year.
Clinic #17 had 4200 annual visits, but only 350 new
patients annually. In contrast to the other HF clinics, the
majority of patients seen at clinic 4 were new (represented
by the red bar), with only a limited number of follow-up
visits (represented by the blue bar).
Table 2 Heart failure disease management scoring instrument (HF-DMSI)
Intervention category Points to be assigned
Recipient 1 = Provider alone
2 = Patient alone
3 = Patient with some inclusion of caregiver
4 = Patient with a caregiver who is central to the intervention
Intervention content
Education and counselling aimed at
supporting self-care
0 = No mention of education
1 = Focus solely on importance of treatment adherence
2 = Focus on treatment adherence including some creative methods of improving adherence
3 = Focus on surveillance but no mention of actions to be taken in response to symptoms (eg, no
flexible diuretic management)
4 = Emphasis on surveillance, management, and evaluation of symptoms in addition to treatment
adherence
Medication management 0 = No mention of medication regimen
1 = Some mention of medications (eg, importance of medication compliance) but not an active part of
the intervention. No attempt to intervene with provider to get patients on an evidence-based
medication regimen
2 = Evidence-based medication regimen advocated but no follow-up with patient or provider to
monitor the suggestion
3 = Medication regimen monitored, attempt made to get the patient on evidence-based medications,
with follow-up monitoring done with patient or provider
Social support Peer support 0 = No mention of a peer support intervention
1 = Peer support mentioned but not integral to intervention
2 = Peer support integral component of intervention
Surveillance by provider:Remote
monitoring
0 = No use of remote monitoring or telehealth
1 = Remote monitoring is used in conjunction with other interventions that form the main intervention
used
2 = Telehealth is essential component of intervention
Delivery personnel 1 = Single generalist provider (eg, physician, nurse, pharmacist)
2 = Single HF expert provider (eg, physician, nurse, pharmacist)
3 = Multidisciplinary intervention
Method of communication 1 = Mechanized via internet or telephone
2 = Person-to-person by telephone
3 = Face-to-face, individual, or in a group
4 = Combined: Face-to-face at least once alone or in a group with individual telephone calls in between
meetings
Intensity and complexity
Duration 1 = ≤1 mo
2 = ≤3 mo
3 = ≤6 mo
4= > 6 mo
Complexity 1 = Low: single contact with little or no follow-up
2 = Moderate: >1 but <4 and/or infrequent contact or contacts of short duration
3 = High: multiple contacts of significant duration
Environment 1 = Hospital: Inpatient only
2 = Clinic/outpatient setting
3 = Home-based
4 = Combination of settings
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Figure 1 Process by which 28 clinics were identified by snowball sampling. Based on interview responses from the initial 15 seed clinics,
full saturation was reached in 3 generations.
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in hospitals with 25.8% being part of an academic insti-
tution. In total, 143 HF clinic physicians worked at the
30 identified clinics. The majority of clinics were run by
cardiologists.Figure 2 Regional Local Health Integration Networks (LHIN) in OntariAccess to allied health professionals
The clinics had on average limited access to in-clinic al-
lied health professionals, as seen in Table 4. Under half
had access to dieticians or pharmacists, with only 6.5%
and 16.1% with in-clinic access to physiotherapists oro depicting regional distribution of identified heart failure clinics.







age 65 years and over
in LHIN
>65 years population per
HF clinic
annual HF discharge per
HF clinic
Erie St. Clair 0 623,300 NA 85,000 NA NA
South West 3 890,100 296,700 125,800 41,900 247
HNHB 2 1,298,300 649,100 192,400 96,200 591
Waterloo Wellington 5 679,700 135,900 76,000 15,200 84
Mississauga Halton 3 1,002,300 334,100 103,400 34,500 155
Central West 0 735,200 NA 65,900 NA NA
Central 2 1,522,800 761,400 183,100 91,600 395
Central East 3 1,419,800 473,300 184,600 61,500 305
Toronto Central 6 1,075,100 179,200 131,800 22,000 118
North Simcoe Muskoka 3 417,000 139,000 59,900 20,000 108
South East 2 457,200 228,600 74,700 37,400 217
Champlain 3 1,131,400 377,100 137,600 45,900 247
North East 1 545,000 545,000 84,900 84,900 626
North West 1 231,900 231,900 31,400 31,400 218
Total 34 12,028,900 353,800 1,536,500 45,200 200
LHIN: Local Health Integration Network; HF: Heart Failure; HNHB: Hamilton Niagara Haldimand Brant; NA: not applicable.
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with a cardiac rehabilitation program and 64.5% where
actively involved with chronic disease management of
another condition, such as diabetes mellitus.Intensity and complexity
The ranges of HF clinic scores on the HF-DMSI are
shown on Figure 4. There was little variation between
the clinics for some elements of the instrument, such as
intervention duration (all scored 4; greater than
6 months). The majority of HF clinics had a formal
medication management protocol, where medications
were monitored and an attempt was made to increase
utilization of evidence-based medications. There was
substantial range in the intensity of education and coun-
selling aimed at supporting self-care. Although all clinics
had some form of education program, these ranged from
programs that focused only on adherence to more com-
prehensive programs that emphasized surveillance, man-
agement and evaluation of symptoms in addition to
treatment adherence. The majority of clinics did not use
remote monitoring at the clinic, although half did con-
tact patients by telephone in between face-to-face eva-
luations. A formal peer support component was
identified in only one HF clinic. Somewhat surprisingly,
although the delivery personnel at the clinic were multi-
disciplinary in approximately 50% of clinics, some had
only either a single generalist or HF expert provider. As
far as environment, all of the clinics were ambulatory
based, with one that was predominantly focussed oninpatients. None were exclusively home-based or had a
home-based component.
Concept mapping
Based on our concept mapping exercise, the expert
panel categorized the 30 identified clinics into three
strata of intensity; 8 clinics were assigned to the low in-
tensity category, with 12 in the medium intensity cat-
egory and 10 in the high intensity group. The mean
scores on the HF-DMSI for these three strata are shown
in Table 5. Although the high intensity clinics had higher
mean scores in 9 of the 10 HF-DMSI categories, this
was most pronounced in the education and counselling,
medication management, delivery personnel and com-
plexity categories. This suggests an implicit weighting of
these categories by our expert panel as revealed by the
concept mapping exercise. In contrast, remote monitor-
ing and the presence of a structured peer-support pro-
gram were believed to be of lesser importance.
Discussion
In this environmental scan of HF clinics in the province
of Ontario, Canada, we were successfully able to identify
34 HF clinics. There was substantial inequity in access
to care, with two LHINs having no identified HF clinics,
and a wide range in the population served by each clinic.
As anticipated, the clinics were varied in structure and
the services offered. The greatest variation in terms of
intensity and complexity was in terms of the education
service offered. Remote monitoring and a home-base
Figure 3 Annual Service Volume of the identified Heart Failure Clinics. The red bar indicates new patients per year, and the blue bar
represents annual patient visits.
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in most clinics.
Multi-disciplinary ambulatory complex disease manage-
ment clinics are increasingly studied as the preferred mo-
dality of ambulatory care delivery for chronic diseases
such as HF [1,3,4,6,17]. Advocates of such clinics highlight
the many randomized clinical trials that show the efficacyof such clinics in reducing mortality and rehospitalisation
[3,18-31]. Importantly, although these clinics are grouped
together in systematic reviews and meta-analyses, there is
heterogeneity in the models evaluated and services
offered [7]. Prior to implementing these clinics in routine
practice, it is critical to understand which components are
central to the intervention. Several meta-analyses have
Table 4 Characteristics of 30 identified clinics
Parameter
PERSONEL
Mean number of Physicians 4.7 (1–8)*
% of clinics with cardiologist 80.6
% of clinics with internists 22.6
% of clinics with family physicians 9.7
% of physicians with heart failure training 80.6
Mean Number of Nurses 2.0 (1–6)*
LOCATION
% Academic 25.8
% Community Based 74.2
Mean Annual Total Visits 1020 (200–1479)*
Mean Annual Total New Patients 139 (25–128)*
% Access to Onsite Echocardiography 80.6
% Access to Onsite Nuclear Cardiology Testing 58.1
% Access to Onsite Angiography 38.7
% Access to Onsite exercise Stress Testing 77.4
Mean Exam Rooms 3.3 (1–4)*
ALLIED HEALTH PROFESSIONALS
% Access to Dietician (In Clinic) 45.2
% Access to Pharmacist (In Clinic) 32.3
% Access to Physiotherapy (In Clinic) 6.5
% Access to Counselor (In Clinic) 16.1
% Affiliated with Cardiac Rehabilitation 87.1
% Involved in other Chronic Disease Management 64.5
* inter-quartile range is shown.
Figure 4 Distribution of scores on 10 categories of Heart Failure Dise
Table 2 for specific definitions of individual scores. Higher scores indicate m
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published literature [3,18-22,27,28]. McAlister and col-
leagues evaluated 29 trials enrolling a total of 5,039
patients [3]. Because of substantial heterogeneity, they
did not report an overall summary statistic [3]. They
found that multi-disciplinary clinics improved mortal-
ity, while tele-monitoring improved re-hospitalization
rates [3]. Holland and colleagues contrasted studies
that incorporated home visits, or between visits tele-
phone calls, to those that were solely hospital or clinic
based [27]. In the 30 trials that were included in their ana-
lysis, they found that reductions in hospitalization were
limited to studies that included either a home-based or
telephone based component to the intervention.
Our study provides a number of insights for policy
makers who are planning the implementation of such
disease management systems in other regions. The pro-
liferation of heart failure clinics in Ontario has occurred
without specific guidance as to their structure, in part
due to the absence of dedicated funding. This has
resulted in considerable variation in important compo-
nents such as education, and the notable absence of key
features such as a home-based component or remote
monitoring. Our findings are consistent with that seen
by Driscoll and colleagues who found substantial vari-
ation in the care provided at HF management programs
across Australia, raising concerns about the quality of
care provided to these patients [32].
Understanding the association between heterogeneity
in clinic model and outcomes such as mortality and re-
hospitalization is the logical next step in order to ad-
dress if quality of care is compromised by this variationase Management Scoring Instrument (HF-DMSI). Please refer to
ore comprehensive program within that category.





High Medium Low p-
value(n = 10) (n = 13) (n = 7)
Recipient 3.3 ± 0.6 3.7 ± 0.5 3.2 ± 0.6 3.0 ± 0.6 .040
Education and counselling aimed at
supporting self-care
3.2 ± 1.0 3.9 ± 0.3 3.1 ± 1.0 2.6 ± 1.1 .011
Medication management 2.7 ± 0.5 3.0 ± 0 2.8 ± 0.4 2.1 ± 0.7 .002
Peer support 0.3 ± 0.5 0.6 ± 0.7 0.2 ± 0.4 0.3 ± 0.5 .147
Remote monitoring 0.7 ± 0.8 1.0 ± 0.8 0.8 ± 0.8 0.1 ± 0.4 .079
Delivery personnel 2.5 ± 0.6 3.0 ± 0 2.5 ± 0.5 2.0 ± 0.8 .002
Method of communication 3.6 ± 0.5 4.0 ± 0 3.5 ± 0.5 3.4 ± 0.5 .018
Duration 4.0 ± 0 4.0 ± 0 4.0 ± 0 4.0 ± 0 -
Complexity 2.6 ± 0.6 3.0 ± 0 2.6 ± 0.5 2.0 ± 0.6 <.001
Environment 2.0 ± 0.2 2.0 ± 0 1.9 ± 0.3 2.0 ± 0 .536
HF-DMSI : Heart Failure Disease Management Scoring Instrument. Results are presented as means ± standard deviations. Please refer to Table 2 for detail
description of HF-DMSI categories and scoring.
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hospitalization who were treated at HF clinics, we
observed a 1-year mortality of 22.8% and a 1-year rehospi-
talisation rate for HF of 44.2%. There was a striking 1.5
fold variation in mortality between clinics and a 2.5 fold
variation in re-hospitalization rates. This highlights the
need to identify which clinic-level components are pre-
dictive of improved outcomes, such that one can provide
clinicians and policy-makers clear guidance when design-
ing specialized HF clinics. These are foci of further re-
search for our group.
Disease management through specialized HF clinics is
recommended by guidelines for patients recently hospi-
talized with HF or at high risk for decomposition [6,17].
Currently, there is a paucity of data on what proportion
of these patients are indeed seen at HF clinics. Although,
this study was not designed to address this question,
based on our estimates of annual HF discharges in the
province and the annual number of new patients seen in
HF clinics, it is likely that an only small proportion of
appropriate patients are cared for at HF clinics. This is
consistent with data from Australia, which suggests only
20% of eligible HF patients are seen at specialized HF
clinics [32]. In addition, the catchment area served by
each HF clinic (353,800 persons) in our study is larger
than that seen in others surveys, such as one in Denmark
(1 HF clinic per 115,000 persons) suggesting that there is
less access in Ontario compared to other regions [32,33].
Moreover, our environmental scan suggests that there is
substantial variation in access to HF clinics across the
province. The absence of specific MOTHLC funding for
the HF clinics may be a contributing factor. Elucidation of
the underlying mechanisms for this disparity will be im-
portant for policy makers.Our study must be interpreted in the context of sev-
eral limitations. First, although we used a number of dif-
ferent methods to locate all HF clinics in the province,
we cannot confirm that all clinics were in fact identified.
We used an instrument to evaluate intensity and complex-
ity; this did not cover all potential service components. In-
deed, it does not include post-discharge planning, which
has been identified by some studies as a critical compo-
nent to reduce early rehospitalisation. Finally, although we
have categorized clinics into intensity strata based on ex-
pert opinion, the relevance of such categories is dependent
on their association with improved patient outcomes.
In summary, through our environmental scan, we
found that despite the absence of specific governmental
funding, there are at least 34 HF multidisciplinary clinics
in operation in the province of Ontario. These clinics
have a wide range of services offered. Further research
on understanding which of these service components
are associated with improved patient outcomes will aid
policy makers and clinicians to determining the optimal
care model for these complex patients.
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